A 13-year-old boy with obesity is hospitalized for COVID-19. He rapidly decompensates, requiring high-flow nasal cannula for hypoxemia (SpO2=91%), and has markedly elevated inflammatory markers, including C-reactive protein. According to treatment guidelines for severe COVID-19 in children, which therapeutic combination is most appropriate for this patient?